Truist Financial
VKTX icon

Truist Financial’s Viking Therapeutics VKTX Stock Holding History

Truist Financial’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$312K Buy
9,579
+1,396
+17% +$44.9K ﹤0.01% 2365
2025
Q4 		$288K Sell
8,183
-309
-4% -$10.9K ﹤0.01% 2361
2025
Q3 		$223K Buy
8,492
+660
+8% +$19.7K ﹤0.01% 2494
2025
Q2 		$208K Sell
7,832
-525
-6% -$13.8K ﹤0.01% 2408
2025
Q1 		$202K Sell
8,357
-483
-5% -$15.3K ﹤0.01% 2363
2024
Q4 		$356K Buy
8,840
+1,912
+28% +$109K ﹤0.01% 2061
2024
Q3 		$439K Sell
6,928
-19,121
-73% -$1.12M ﹤0.01% 1935
2024
Q2 		$1.38M Buy
26,049
+20,350
+357% +$1.33M ﹤0.01% 1455
2024
Q1 		$467K Buy
+5,699
New +$254K ﹤0.01% 2004

Other funds holding VKTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return